Form 4 for IMNM Immunome Inc.
Accepted 2024-11-25 00:00:00 ET · period of report 2024-11-21 · accession 0001415889-24-027599 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-25 | 2024-11-21 | IMNM | Lechleider Robert | Chief Medical Off | P - Purchase | $9.48 | +15.8K | 15.8K | New | +$149.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-21 | P | A | 15,805 | $9.48 | 15,805 | D | — | — | (F1) The purchase price for the reported transactions was $9.478. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, the Reporting Person will provide the full information regarding the securities purchased. |